|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
Assessment of Eligibility and Utilization of Accelerated Partial Breast Irradiation in Korean
Breast Cancer
Patients (KROG 22-15)
Seok-Joo Chun, Ji Hwan Jo, Yong Bae Kim, Sangjoon Park, Sung-Ja Ahn, Su Ssan Kim, Kyubo Kim, Kyung Hwan Shin
Cancer Res Treat.
2024;56(2):549-556. Published online December 8, 2023 DOI:
https://doi.org/10.4143/crt.2023.1109
Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with
Breast Cancer
Thi Xuan Mai Tran, Soyeoun Kim, Chihwan Cha, Boyoung Park
Cancer Res Treat.
2024;56(2):522-530. Published online October 30, 2023 DOI:
https://doi.org/10.4143/crt.2023.729
Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with
Breast Cancer
: A Prospective Cohort Study
Danbee Kang, Seri Park, Hyo Jung Kim, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Ji-Yeon Kim, Seok Jin Nam, Juhee Cho, Yeon Hee Park
Cancer Res Treat.
2024;56(1):125-133. Published online September 4, 2023 DOI:
https://doi.org/10.4143/crt.2023.673
Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor–Positive Metastatic
Breast Cancer
Seul-Gi Kim, Min Hwan Kim, Sejung Park, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Byeong Woo Park, Seung Il Kim, Jung Hwan Ji, Joon Jeong, Kabsoo Shin, Jieun Lee, Hyung-Don Kim, Kyung Hae Jung, Joohyuk Sohn
Cancer Res Treat.
2023;55(4):1198-1209. Published online April 11, 2023 DOI:
https://doi.org/10.4143/crt.2022.1543
Crossref 1
Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic
Breast Cancer
Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Cancer Res Treat.
2022;54(4):1130-1137. Published online January 17, 2022 DOI:
https://doi.org/10.4143/crt.2021.1103
Web of Science 2
Crossref 3
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced
Breast Cancer
: A Single-Institutional Clinical Experience
Ji-Yeon Kim, Seok Jin Nam, Jeong Eon Lee, Jonghan Yu, Byung Joo Chae, Se Kyung Lee, Jai Min Ryu, Jin Seok Ahn, Young-Hyuck Im, Seok Won Kim, Yeon Hee Park
Cancer Res Treat.
2022;54(4):1091-1098. Published online January 10, 2022 DOI:
https://doi.org/10.4143/crt.2021.901
Web of Science 7
Crossref 7
Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term
Breast Cancer
Survivors
Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Na Yeon Kim, Sungkeun Shim, Ho Young Kim, Danbee Kang, Juhee Cho, Eunsook Lee, Yoon Jung Chang, Hyunsoon Cho
Cancer Res Treat.
2022;54(4):1065-1073. Published online December 8, 2021 DOI:
https://doi.org/10.4143/crt.2021.835
Web of Science 15
Crossref 18
Clinicopathological Characterization of Double Heterozygosity for
BRCA1
and
BRCA2
Variants in Korean
Breast Cancer
Patients
Yoon Ju Bang, Won Kyung Kwon, Seok Jin Nam, Seok Won Kim, Byung-Joo Chae, Se Kyung Lee, Jai Min Ryu, Jong-Won Kim, Jonghan Yu, Jeong Eon Lee
Cancer Res Treat.
2022;54(3):827-833. Published online October 13, 2021 DOI:
https://doi.org/10.4143/crt.2021.791
Web of Science 1
Crossref 1
Effect of Postoperative Radiotherapy after Primary Tumor Resection in De Novo Stage IV
Breast Cancer
: A Multicenter Retrospective Study (KROG 19-02)
Yeon Joo Kim, Yeon-Joo Kim, Yong Bae Kim, Ik Jae Lee, Jeanny Kwon, Kyubo Kim, Jihye Cha, Myungsoo Kim, In Young Jo, Jung Hoon Kim, Jaehyeon Park, Jin Hee Kim, Juree Kim, Kyung Hwan Shin, Su Ssan Kim
Cancer Res Treat.
2022;54(2):478-487. Published online July 12, 2021 DOI:
https://doi.org/10.4143/crt.2021.632
Web of Science 3
Crossref 4
β1,4-Galactosyltransferase V Modulates
Breast Cancer
Stem Cells through Wnt/β-catenin Signaling Pathway
Wei Tang, Meng Li, Xin Qi, Jing Li
Cancer Res Treat.
2020;52(4):1084-1102. Published online May 27, 2020 DOI:
https://doi.org/10.4143/crt.2020.093
Web of Science 25
Crossref 8
Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive
Breast Cancer
: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis
Ying Lin, Mingxi Lin, Jian Zhang, Biyun Wang, Zhonghua Tao, Yiqun Du, Sheng Zhang, Jun Cao, Leiping Wang, Xichun Hu
Cancer Res Treat.
2020;52(4):1059-1066. Published online April 24, 2020 DOI:
https://doi.org/10.4143/crt.2019.633
Web of Science 30
Crossref 16
RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative
Breast Cancer
Tian-Hao Weng, Min-Ya Yao, Xiang-Ming Xu, Chen-Yu Hu, Shu-Hao Yao, Yi-Zhi Liu, Zhi-Gang Wu, Tao-Ming Tang, Pei-Fen Fu, Ming-Hai Wang, Hang-Ping Yao
Cancer Res Treat.
2020;52(3):973-986. Published online April 22, 2020 DOI:
https://doi.org/10.4143/crt.2019.726
Web of Science 14
Crossref 14
Detection of Germline Mutations in
Breast Cancer
Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon, Dong-Young Noh, Sun-Young Kong, Wonshik Han
Cancer Res Treat.
2020;52(3):697-713. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.559
Web of Science 26
Crossref 25
PIK3CA
H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative
Breast Cancer
Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
Cancer Res Treat.
2020;52(3):689-696. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.497
Web of Science 27
Crossref 25
Prevalence of
PALB2
Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan
Muhammad Usman Rashid, Faiz Ali Khan, Noor Muhammad, Asif Loya, Ute Hamann
Cancer Res Treat.
2019;51(3):992-1000. Published online October 11, 2018 DOI:
https://doi.org/10.4143/crt.2018.356
Web of Science 7
Crossref 8
Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):280-288. Published online May 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.079
Web of Science 10
Crossref 9
Psychosocial Health of Disease-Free
Breast Cancer
Survivors Compared with Matched Non-cancer Controls
Boyoung Park, Moo Hyun Lee, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):178-186. Published online April 5, 2018 DOI:
https://doi.org/10.4143/crt.2017.585
Web of Science 5
Crossref 5
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic
Breast Cancer
Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro
Cancer Res Treat.
2019;51(1):43-52. Published online February 14, 2018 DOI:
https://doi.org/10.4143/crt.2017.562
Web of Science 30
Crossref 34
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic
Breast Cancer
Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves
Cancer Res Treat.
2018;50(4):1226-1237. Published online December 28, 2017 DOI:
https://doi.org/10.4143/crt.2017.446
Web of Science 9
Crossref 7
Evaluation of the Benefit of Radiotherapy in Patients with Occult
Breast Cancer
: A Population-Based Analysis of the SEER Database
Byoung Hyuck Kim, Jeanny Kwon, Kyubo Kim
Cancer Res Treat.
2018;50(2):551-561. Published online June 1, 2017 DOI:
https://doi.org/10.4143/crt.2017.189
Web of Science 12
Crossref 10
Clinically Significant Unclassified Variants in
BRCA1
and
BRCA2
Genes among Korean
Breast Cancer
Patients
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2017;49(3):627-634. Published online September 13, 2016 DOI:
https://doi.org/10.4143/crt.2016.292
Web of Science 12
Crossref 10
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative
Breast Cancer
In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
Cancer Res Treat.
2017;49(3):569-577. Published online September 12, 2016 DOI:
https://doi.org/10.4143/crt.2016.289
Web of Science 66
Crossref 63
Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic
Breast Cancer
in Korea
Seung Hoon Beom, Jisu Oh, Tae-Yong Kim, Kyung-Hun Lee, Yaewon Yang, Koung Jin Suh, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, Tae-You Kim, Dong-Young Noh, Seock-Ah Im
Cancer Res Treat.
2017;49(2):454-463. Published online August 23, 2016 DOI:
https://doi.org/10.4143/crt.2016.259
Web of Science 1
Crossref 1
Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs
Robert S. Kerbel
Cancer Res Treat.
2007;39(4):150-159. Published online December 31, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.4.150
Crossref 37
A Locally Advanced
Breast Cancer
with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and Taxane-based Neoadjuvant Chemotherapy: A Case Report
Se Hyun Kim, Hyun Cheol Chung, Jaeheon Jeong, Ji Hoon Kim, Sun Young Rha, Joong Bae Ahn, Nam Hoon Cho, Hei-Cheul Jeung
Cancer Res Treat.
2007;39(3):134-137. Published online September 30, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.3.134
Crossref 3
Effects of the Expression of Leptin and Leptin Receptor (OBR) on the Prognosis of Early-stage
Breast Cancer
s
Yongnam Kim, Si-Young Kim, Jae Jin Lee, Jeongho Seo, Youn-Wha Kim, Suck Hwan Koh, Hwi-Joong Yoon, Kyung Sam Cho
Cancer Res Treat.
2006;38(3):126-132. Published online June 30, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.3.126
Crossref 11
Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic
Breast Cancer
Sun-Young Kong, Do Hoon Lee, Eun Sook Lee, Susan Park, Keun Seok Lee, Jungsil Ro
Cancer Res Treat.
2006;38(1):35-39. Published online February 28, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.1.35
Crossref 12
Expression of Cyclooxygenase-2 in Human
Breast Cancer
: Relationship with HER-2/neu and other Clinicopathological Prognostic Factors
Eunmi Nam, Soon Nam Lee, Seock-Ah Im, Do-Yeun Kim, Kyoung Eun Lee, Sun Hee Sung
Cancer Res Treat.
2005;37(3):165-170. Published online June 30, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.3.165
Crossref 5
The Differential Gene Expression Profiles between Sensitive and Resistant
Breast Cancer
Cells to Adriamycin by cDNA Microarray
Myung-Ju Ahn, Ki-Hwan Lee, Joon-Ik Ahn, Dong-Hyun Yu, Hye-Sook Lee, Jung-Hye Choi, Joung Soon Jang, Jong Min Bae, Yong-Sung Lee
Cancer Res Treat.
2004;36(1):43-49. Published online February 29, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.1.43
Crossref 8
Korean
Breast Cancer
Data of 1997
J Korean Cancer Assoc.
1999;31(6):1202-1209.
1
2
3
4
Journal Impact Factor 4.6